Long-term follow-up study of Kudo Type-5 elbow prosthesis in patients with rheumatoid arthritis: minimum 10-year clinical outcomes.

J Shoulder Elbow Surg

Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. Electronic address:

Published: December 2024

Objectives: Rheumatoid arthritis often leads to debilitating damage in the elbow joint, which may require total elbow arthroplasty (TEA). The Kudo TEA is one of the unlinked type prostheses with reportedly favorable outcomes. However, there is limited information available regarding its long-term performance. This retrospective study aimed to evaluate the long-term survivorship and identify risk factors associated with failure of the Kudo Type-5 TEA in patients with rheumatoid arthritis (RA), specifically exceeding 10 years.

Methods: Patients with RA who underwent TEA with the Kudo Type-5 prosthesis from 1998 to 2009, with a minimum ten-year follow-up, were included. Failure, defined as revision surgery or radiographic loosening, was assessed using the Kaplan-Meier method. The patients' demographic data, radiographic measurements, range of motion, Mayo elbow performance score (MPES), and the material of the ulnar component were compared between the elbows with and without failure. Univariate analysis identified factors affecting long-term survivorship.

Results: Among 49 elbows in 38 patients with a mean follow-up of 13.4 years, significant improvements in flexion range and MPES were observed. The failure rate was 39%, occurring in 19 elbows. Among these failures, 13 cases were attributed to issues with the ulnar component, making it the most common cause. The overall survivorship rate of the Kudo Type-5 prosthesis at ten years was 78%, as calculated using the Kaplan-Meier method. Factors associated with a higher failure risk included a shorter duration from RA onset to surgery (17.2 ± 5.8 years vs. 23.3 ± 8.7 years; p = 0.01), a lower preoperative stability score of MPES (6.6 ± 4.1 vs. 9.3 ± 1.7; p < 0.01), larger implant deviation assessed by the implant deviation index (9.3 ± 1.3% vs. 5.4 ± 1.1%; p = 0.03), and the use of the all-polyethylene ulnar component (79.0% vs. 46.7%; p = 0.04).

Conclusion: Although the Kudo Type-5 prosthesis demonstrated satisfactory results in patients with RA, failures occurred to some extent over a long-term follow-up period. Careful monitoring should be conducted, particularly in cases with a short duration from RA onset to surgery, preoperative instability, misalignment of the implant and the use of the all-polyethylene ulnar component.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jse.2024.10.025DOI Listing

Publication Analysis

Top Keywords

kudo type-5
20
ulnar component
16
rheumatoid arthritis
12
type-5 prosthesis
12
long-term follow-up
8
patients rheumatoid
8
tea kudo
8
factors associated
8
kaplan-meier method
8
score mpes
8

Similar Publications

Long-term follow-up study of Kudo Type-5 elbow prosthesis in patients with rheumatoid arthritis: minimum 10-year clinical outcomes.

J Shoulder Elbow Surg

December 2024

Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. Electronic address:

Objectives: Rheumatoid arthritis often leads to debilitating damage in the elbow joint, which may require total elbow arthroplasty (TEA). The Kudo TEA is one of the unlinked type prostheses with reportedly favorable outcomes. However, there is limited information available regarding its long-term performance.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the long-term outcomes (15 years) of the Kudo type-5 total elbow arthroplasty (TEA) in patients with rheumatoid arthritis (RA), revealing significant improvement in elbow flexion and performance scores post-surgery.
  • Out of 29 elbows analyzed, complications occurred, including fractures and dislocations, with a 24.1% rate of aseptic loosening requiring revisions for five elbows.
  • The overall survival rate of the Kudo TEA was 81% at 15 years, with a notable finding that incorrect ulnar component insertion angles led to a higher risk of needing revisions.
View Article and Find Full Text PDF

Outcomes of Revision Unlinked Total Elbow Arthroplasty for Rheumatoid Elbow.

J Hand Surg Asian Pac Vol

August 2023

Department of Orthopaedic Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Kasumi, Minami-ku, Hiroshima, Japan.

Although unlinked total elbow arthroplasty (TEA) is a treatment option for end-stage rheumatoid arthritis (RA) of the elbow, its long-term outcomes were inferior. Moreover, revision TEA could be technically challenging. The unlinked TEA procedure comprises the ease of implant removal at revision and advantage of bone preservation.

View Article and Find Full Text PDF

Identifying different species of the genus Atractylodes which are commonly used in Chinese and Japanese traditional medicine, using chromatographic approaches can be difficult. H NMR metabolic profiling of DNA-authenticated, archived rhizomes of the genus Atractylodes was performed for genetic and chemical evaluation. The ITS region of the nuclear rDNA was sequenced for five species, A.

View Article and Find Full Text PDF

Macroscopic investigation of failed Kudo type 5 total elbow arthroplasty.

J Shoulder Elbow Surg

August 2018

Department of Orthopaedic Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Background: On the basis of the intra-articular findings during Kudo type 5 elbow prosthesis revision surgery, we infer the mechanisms leading to implant failure.

Materials And Methods: We performed primary Kudo type 5 total elbow arthroplasty on 60 rheumatoid elbows in 45 patients between 1994 and 2003. Revision surgery was performed in 8 patients (9 elbows) because of implant failure.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!